Baylor Study Reveals Role of Newly Inherited DNA Variants in Recessive Diseases
A team of researchers from Baylor College of Medicine, including PNRI’s own Dr. Cláudia Carvalho, conducted a decade-long exploration into Turkish genetics, uncovering a vital piece of the puzzle behind why some rare diseases emerge.
Carvalho Lab
Razor clams, geoducks battle to be WA’s top clam
In the ongoing battle for Washington’s official state clam, the Pacific razor clam faces tough competition from geoduck enthusiasts. But amidst the clamor, PNRI scientist Michael Metzger sheds light on the broader challenges these iconic shellfish face due to climate change.
Metzger Lab
Yeast genetics collaboration yields hope for improved diagnosis of urea cycle disorders
The National Urea Cycle Disorders Foundation (NUCDF) showcased PNRI’s Dudley Lab for its groundbreaking genetic screening tool. The Dudley Lab’s research not only accelerates diagnosis but may also pave the way for personalized treatments, improving patient outcomes.
Dudley Lab
PNRI Welcomes Dr. Jack Faris as Interim CEO
Science in Seattle covers Dr. Jack Faris’s return to PNRI as interim CEO—bringing seasoned leadership and vision.
Applications Open for PNRI’s 2024 Summer Undergraduate Research Internship
Science in Seattle highlights PNRI’s 2024 SURI: paid internships, real projects, symposia, and mentorship—apply now.
Bold Breakthroughs: PNRI’s Night of Celebration, Science, and Hope
Science in Seattle recaps “Bold Breakthroughs”—PNRI’s energizing return to in-person celebration of discovery and hope.
Bizarre Cancer Has Been Spreading Among Shellfish for Centuries, Studies Find
Carl Zimmer from The New York Times interviewed PNRI’s Dr. Michael Metzger about a study just published in the journal Nature Cancer. Dr. Metzger and a global team of scientists uncovered a transmissible cancer lineage in soft-shell clams more than 200 years old. Their findings not only reshape our understanding of how cancer evolves but offer insights that could help develop novel strategies for blocking cancer in humans and other species.
Metzger Lab
COVID Cleared of Increasing Risk of Type 1 Diabetes in Kids?
In a study recently published in the New England Journal of Medicine, researchers from PNRI’s Hagopian Lab and TEDDY Study colleagues found no evidence to suggest a link between COVID-19 and the development of type 1 diabetes in children. Their findings stand in contrast to other recent studies that suggested a link between the virus and the disease.
Hagopian Lab
Ornithine transcarbamylase (OTC) deficiency with Aimée Dudley, Andrea Gropman, and Tresa Warner
In this podcast episode, PNRI Senior Investigator Dr. Aimée Dudley joins Dr. Andrea Gropman, Chief of Neurogenetics and Neurodevelopmental Pediatrics at Children’s National Hospital, and Tresa Warner, a parent of a child living with OTC deficiency and the President of the Board of Directors of the National Urea Cycle Disorders Foundation, to discuss a novel genetic screening tool that offers hope to babies born with ornithine transcarbamylase deficiency (OTC deficiency), a life-threatening metabolic disorder.
Dudley Lab
Tribe, Partners Discover Cancer in Cockles
The Northwest Indian Fisheries Commission describes how the Suquamish Tribe and PNRI’s Metzger Lab are working together to better understand how a cancer affects the local cockle population – a traditional food for tribal members that started to disappear over the past few decades.
Metzger Lab